This is an absolutely fantastic resource for anyone looking at building healthtech solutions, particularly if you are trying to raise capital early on. Addressing the very likely risks early on allows you to demonstrate a logical business case and if anything, reassure yourself that you are dedicating time/effort to a viable and robust proposition. We fell short on many of the suggestions Wesley mentions but you learn from it! #healthtech #technology #risk
It started with a pitch 🗣 My meeting with a VC at #LondonTechWeek inspired me to put pen to paper and share a brief survival guide for early-stage health tech start-ups traversing the chasm to commercial traction and a £1m+ funding round. Please join the conversation to share your perspectives on what it takes for potentially game-changing innovations to get to market, scale, and impact the lives of millions of people around the world. Hat tip to Martin Komnacky and UNIQA Ventures for encouraging a culture of outreach to early-stage innovators. 🙇♂️ Chris Sawyer Raviv Haddi Martin Rennison Ian Smith Jon Warner Jack (Tasuku) Toyama Euan McComiskie Malachy Finnegan Gabriella Spinelli Alexander Bolotov Paulina Bondaronek, PhD Sarah Salem Doug Wright Kevin McDonnell Rob Ferry Guillermo Flor Shehla Rooney, PT, GCS Erkan Hassan, Pharm. D., FCCM Isabel Van De Keere, PhD Chris Fernandes David Bell, Ph.D. Will Gibbs TJ Patel Ralph Stenzel Nicholas May Kapil Sugand Toby Ryan Yasmin Mansour Dr. John Lee Allen Jeffrey Kazmucha Mark Howard MSc, PVRA Liz Hawes Arash Angadji Mark Wilkinson Ben Wilkins Michael Hart Laurence Girard Erica Meloe
Thanks Chris Fernandes! Do not be fooled, success is built on failure.